Description
RADIOPHARMACEUTICAL DELIVERIES TO NUCLEAR MEDICINE - MODIFICATION ISSUED TO REMOVE UNUSED FUNDS AND CLOSE OUT THIS ACTION.
Base award description: RADIOPHARMACEUTICAL DELIVERIES TO NUCLEAR MEDICINE
Modification chain · 5 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-06-30+$14,000= $14,000
- Mod P000012017-08-02+$40,040= $54,040
- Mod P000022017-09-29+$19,880= $73,920
- Mod P000032017-11-07+$30,000= $103,920
- Mod P000042018-01-18-$3,697= $100,223
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-06-30 | +$14,000 | $14,000 | RADIOPHARMACEUTICAL DELIVERIES TO NUCLEAR MEDICINE |
| Mod P00001· FUNDING ONLY ACTION | 2017-08-02 | +$40,040 | $54,040 | RADIOPHARMACEUTICAL DELIVERIES TO NUCLEAR MEDICINE - MODIFICATION P00001 ISSUED TO ADD FUNDING TO THIS ORDER -… |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2017-09-29 | +$19,880 | $73,920 | RADIOPHARMACEUTICAL DELIVERIES TO NUCLEAR MEDICINE - MODIFICATION P00002 ISSUED TO ADD FUNDING TO THIS ORDER A… |
| Mod P00003· FUNDING ONLY ACTION | 2017-11-07 | +$30,000 | $103,920 | RADIOPHARMACEUTICAL DELIVERIES TO NUCLEAR MEDICINE - MODIFICATION P00002 ISSUED TO ADD FUNDING TO THIS ORDER A… |
| Mod P00004· FUNDING ONLY ACTION | 2018-01-18 | −$3,697 | $100,223 | RADIOPHARMACEUTICAL DELIVERIES TO NUCLEAR MEDICINE - MODIFICATION ISSUED TO REMOVE UNUSED FUNDS AND CLOSE OUT… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI CETPVZL5RQS3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926N0409 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $34,735 | FY2026 |
| 36C24826N0693 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $111,150 | FY2026 |
| 36C25226N0456 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $34,735 | FY2026 |
| 36C26326F0080 | NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS | $27,788 | FY2026 |
| 36C25726N0272 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $257,789 | FY2026 |
| 36C25726D0056 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under 6505 from 583-INDIANAPOLIS(00583) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25018F0290 | ABBOTT LABORATORIES INC. | 583-INDIANAPOLIS(00583) | $13,793 | FY2018 |
| VA25017F4218 | ALEXION PHARMACEUTICALS INC | 583-INDIANAPOLIS(00583) | $55,584 | FY2017 |
| VA25017J4216 | PFIZER INC | 583-INDIANAPOLIS(00583) | $14,554 | FY2017 |
| VA25017J4118 | SHIRE US INC. | 583-INDIANAPOLIS(00583) | $41,697 | FY2017 |
| VA25017F3675 | ALEXION PHARMACEUTICALS INC | 583-INDIANAPOLIS(00583) | $55,584 | FY2017 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25017P3729_3600_-NONE-_-NONE- · retrieved 2026-09-26.